Sinon Corporation (1712.TW)
TWD 40.35
(-1.1%)
TWD 40.35
(-1.1%)
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2023 | 6.79 Billion TWD | -13.9% |
| 2022 | 7.89 Billion TWD | -7.19% |
| 2021 | 8.5 Billion TWD | 8.38% |
| 2020 | 7.84 Billion TWD | -4.15% |
| 2019 | 8.18 Billion TWD | 3.68% |
| 2018 | 7.89 Billion TWD | -7.75% |
| 2017 | 8.56 Billion TWD | -12.93% |
| 2016 | 9.83 Billion TWD | -3.44% |
| 2015 | 10.18 Billion TWD | -4.99% |
| 2014 | 10.71 Billion TWD | 16.25% |
| 2013 | 9.21 Billion TWD | 23.15% |
| 2012 | 7.48 Billion TWD | 32.41% |
| 2011 | 5.65 Billion TWD | 39.88% |
| 2010 | 4.04 Billion TWD | -4.36% |
| 2009 | 4.22 Billion TWD | 0.0% |
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2024 Q1 | 8.16 Billion TWD | 20.19% |
| 2024 Q2 | 7.14 Billion TWD | -12.5% |
| 2023 Q3 | 7.04 Billion TWD | -0.61% |
| 2023 Q1 | 8.24 Billion TWD | 4.47% |
| 2023 Q4 | 6.79 Billion TWD | -3.56% |
| 2023 FY | 6.79 Billion TWD | -13.9% |
| 2023 Q2 | 7.09 Billion TWD | -14.02% |
| 2022 FY | 7.89 Billion TWD | -7.19% |
| 2022 Q4 | 7.89 Billion TWD | -12.87% |
| 2022 Q3 | 9.06 Billion TWD | -6.3% |
| 2022 Q1 | 9.51 Billion TWD | 11.87% |
| 2022 Q2 | 9.66 Billion TWD | 1.61% |
| 2021 Q1 | 8.13 Billion TWD | 3.65% |
| 2021 Q4 | 8.5 Billion TWD | 13.56% |
| 2021 Q3 | 7.49 Billion TWD | -2.03% |
| 2021 FY | 8.5 Billion TWD | 8.38% |
| 2021 Q2 | 7.64 Billion TWD | -6.02% |
| 2020 Q2 | 8.15 Billion TWD | -5.08% |
| 2020 Q1 | 8.59 Billion TWD | 4.96% |
| 2020 Q3 | 7.67 Billion TWD | -5.9% |
| 2020 Q4 | 7.84 Billion TWD | 2.23% |
| 2020 FY | 7.84 Billion TWD | -4.15% |
| 2019 Q3 | 8.1 Billion TWD | -2.15% |
| 2019 Q1 | 8.81 Billion TWD | 11.6% |
| 2019 Q2 | 8.28 Billion TWD | -5.98% |
| 2019 FY | 8.18 Billion TWD | 3.68% |
| 2019 Q4 | 8.18 Billion TWD | 0.98% |
| 2018 Q2 | 8.54 Billion TWD | -3.55% |
| 2018 Q4 | 7.89 Billion TWD | -3.21% |
| 2018 FY | 7.89 Billion TWD | -7.75% |
| 2018 Q1 | 8.86 Billion TWD | 3.53% |
| 2018 Q3 | 8.16 Billion TWD | -4.55% |
| 2017 FY | 8.56 Billion TWD | -12.93% |
| 2017 Q4 | 8.56 Billion TWD | -2.85% |
| 2017 Q3 | 8.81 Billion TWD | -3.22% |
| 2017 Q2 | 9.1 Billion TWD | -1.1% |
| 2017 Q1 | 9.2 Billion TWD | -6.37% |
| 2016 Q4 | 9.83 Billion TWD | -1.78% |
| 2016 Q3 | 10.01 Billion TWD | -3.1% |
| 2016 Q2 | 10.33 Billion TWD | -2.72% |
| 2016 FY | 9.83 Billion TWD | -3.44% |
| 2016 Q1 | 10.61 Billion TWD | 4.29% |
| 2015 Q1 | 11 Billion TWD | 2.65% |
| 2015 Q3 | 11.1 Billion TWD | -0.07% |
| 2015 Q2 | 11.11 Billion TWD | 1.04% |
| 2015 Q4 | 10.18 Billion TWD | -8.32% |
| 2015 FY | 10.18 Billion TWD | -4.99% |
| 2014 Q2 | 9.86 Billion TWD | 2.34% |
| 2014 FY | 10.71 Billion TWD | 16.25% |
| 2014 Q4 | 10.71 Billion TWD | 7.02% |
| 2014 Q3 | 10.01 Billion TWD | 1.48% |
| 2014 Q1 | 9.64 Billion TWD | 4.59% |
| 2013 Q2 | 8.75 Billion TWD | 5.53% |
| 2013 FY | 9.21 Billion TWD | 23.15% |
| 2013 Q1 | 8.29 Billion TWD | 10.84% |
| 2013 Q3 | 9.22 Billion TWD | 5.33% |
| 2013 Q4 | 9.21 Billion TWD | -0.04% |
| 2012 Q3 | 7.56 Billion TWD | 13.2% |
| 2012 Q1 | 5.87 Billion TWD | 3.98% |
| 2012 Q2 | 6.68 Billion TWD | 13.66% |
| 2012 Q4 | 7.48 Billion TWD | -1.03% |
| 2012 FY | 7.48 Billion TWD | 32.41% |
| 2011 Q2 | 4.94 Billion TWD | 15.95% |
| 2011 Q3 | 5.08 Billion TWD | 2.68% |
| 2011 Q4 | 5.65 Billion TWD | 11.24% |
| 2011 FY | 5.65 Billion TWD | 39.88% |
| 2011 Q1 | 4.26 Billion TWD | 5.62% |
| 2010 FY | 4.04 Billion TWD | -4.36% |
| 2010 Q4 | 4.04 Billion TWD | 0.0% |
| 2009 FY | 4.22 Billion TWD | 0.0% |
| Name | Total Liabilities | Total Liabilities Difference |
|---|---|---|
| Taiwan Fertilizer Co., Ltd. | 26.78 Billion TWD | 74.623% |
| All Cosmos Bio-Tech Holding Corporation | 859.54 Million TWD | -690.815% |
| CH Biotech R&D Co., Ltd. | 1.12 Billion TWD | -502.038% |